Emergent BioSolutions Gets Up to $22.3 Million Anthrax Vaccine Contract Modification
The modification exercises an option period under an existing Pentagon contract to supply BioThrax. The initial delivery details are truncated.
Related stories
Kakao Plans KRW 150 Billion Share Cancellation
Kakao plans to cancel shares worth KRW 150 billion.
M impact | EQUITY | Nov 05, 2026, 12:10 AM UTC
Toyota Motor shares rise 7.4%
M impact | EQUITY | Nov 05, 2026, 12:06 AM UTC
Global market picture: S&P 500 +1.65%, Nasdaq 100 +0.72%; EUR/USD +0.41%, WTI -8.05%
Global market picture. US index futures: S and P futures is up 1.65 percent, Nasdaq futures is up 0.72 percent, Dow futures is up 3.14 percent and Russell futures is up 1.48 percen
M impact | EQUITY | Nov 05, 2026, 12:06 AM UTC
South Korea’s KOSPI falls 2%
M impact | EQUITY | Nov 05, 2026, 12:05 AM UTC
KOSPI falls 2%
M impact | EQUITY | Nov 05, 2026, 12:05 AM UTC
NAB Full-Year Cash Profit Misses Estimates as Provisions Rise
Australia's NAB reported full-year cash profit below estimates and higher provisions.
M impact | EQUITY | Nov 04, 2026, 11:59 PM UTC